Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Growth Mid Cap Fund | SBI MIDCAP FUND | |
|---|---|---|
| Category | Mid Cap | Mid Cap |
| Plan | Regular | Regular |
| Fund house | Nippon India | SBI |
| NAV | ₹4,471.1655 | ₹233.5401 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 20.6 years | 20.6 years |
| Expense ratio | 1.5% | 1.8% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 69.30 | 30.90 |
Returns
| Nippon India Growth Mid Cap Fund | SBI MIDCAP FUND | |
|---|---|---|
| 1 month | +5.38% | +2.94% |
| 3 months | −2.22% | −3.93% |
| 6 months | +2.18% | −0.48% |
| YTD | +5.84% | −1.06% |
| 1 year | +4.39% | −1.17% |
| 3 years (CAGR) | +15.54% | +8.31% |
| 5 years (CAGR) | +16.08% | +10.38% |
| 10 years (CAGR) | +18.18% | +13.50% |
| Since launch | +15.35% | +12.80% |
Risk
| Nippon India Growth Mid Cap Fund | SBI MIDCAP FUND | |
|---|---|---|
| Volatility | 17.9% | 16.3% |
| Downside volatility | 11.8% | 11.7% |
| Sharpe | 0.50 | 0.11 |
| Sortino | 0.76 | 0.16 |
| Calmar | 0.77 | 0.46 |
| Return / risk | 0.87 | 0.51 |
| Deepest fall | −62.65% | −78.65% |
| Days to recover | 546 | 1911 |
| Below its high | −2.78% | −6.96% |
Against benchmark
| Nippon India Growth Mid Cap Fund | SBI MIDCAP FUND | |
|---|---|---|
| Alpha | +1.61% | −4.13% |
| Beta | 0.96 | 0.86 |
| R² | 95.9% | 93.0% |
| Up capture | 99.0% | 76.7% |
| Down capture | 91.6% | 87.9% |
| Tracking error | 3.7% | 5.1% |
| Information ratio | 0.35 | −1.03 |
| Treynor | 0.08 | 0.01 |
Consistency
| Nippon India Growth Mid Cap Fund | SBI MIDCAP FUND | |
|---|---|---|
| Best 1-year | +136.86% | +163.68% |
| Middle 1-year | +12.56% | +12.62% |
| Worst 1-year | −56.31% | −74.48% |
| 1-year periods with a loss | 22.0% | 24.7% |
| Middle 3-year | +17.53% | +16.19% |
| Positive months | 69.4% | 69.4% |
| Best day | +4.57% | +3.20% |
| Worst day | −7.42% | −4.12% |
| Worst 5% day | −1.82% | −1.52% |
| Positive days | 54.9% | 53.3% |
| NAVs a year | 247 | 252 |
SIP of ₹10,000 a month
| Nippon India Growth Mid Cap Fund | SBI MIDCAP FUND | |
|---|---|---|
| 5-year XIRR | +16.46% | +9.04% |
| 5-year value | ₹9,12,789 | ₹7,56,872 |
| 3-year XIRR | +9.32% | +2.85% |
| 1-year XIRR | +7.21% | +0.21% |
Holdings overlap i
| Nippon India Growth Mid Cap Fund | SBI MIDCAP FUND | |
|---|---|---|
| Nippon India Growth Mid Cap Fund | — | 27% |
| SBI MIDCAP FUND | 27% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India Growth Mid Cap Fund | SBI MIDCAP FUND |
|---|---|---|
| Multi Commodity Exchange of India Limited | 3.20% | 3.15% |
| The Federal Bank Limited | 2.85% | 2.74% |
| ICICI Lombard General Insurance Company Limited | 2.10% | 2.84% |
| Bharat Forge Limited | 1.79% | 2.08% |
| One 97 Communications Limited | 2.37% | 1.54% |
| Indus Towers Limited | 1.39% | 1.60% |
| Bharat Heavy Electricals Limited | 1.35% | 2.61% |
| Shree Cement Limited | 1.27% | 2.58% |
| FSN E-Commerce Ventures Limited | 1.20% | 2.82% |
| Supreme Industries Limited | 1.00% | 2.97% |
| Lupin Limited | 0.90% | 1.90% |
| Fortis Healthcare Limited | 2.67% | 0.88% |
| Swiggy Limited | 0.87% | 1.43% |
| Torrent Power Limited | 0.84% | 3.42% |
| Sundaram Finance Limited | 0.78% | 2.65% |
| Page Industries Limited | 0.68% | 1.64% |
| Schaeffler India Limited | 0.66% | 1.60% |
| Carborundum Universal Limited | 0.65% | 1.35% |
| Mahindra & Mahindra Financial Services Limited | 0.62% | 0.70% |
| Persistent Systems Limited | 2.03% | 0.49% |
| Dalmia Bharat Limited | 0.47% | 1.37% |
| Sundram Fasteners Limited | 0.44% | 1.86% |
| Colgate Palmolive (India) Limited | 0.42% | 1.29% |
| J.K. Cement Limited | 0.30% | 1.07% |
| Glaxosmithkline Pharmaceuticals Limited | 0.29% | 1.32% |
Sectors and company size
| Nippon India Growth Mid Cap Fund | SBI MIDCAP FUND | |
|---|---|---|
| Large companies | 22.4% | 11.9% |
| Mid companies | 66.0% | 66.6% |
| Small companies | 11.5% | 17.7% |
| Top 10 holdings | 25.7% | 28.9% |
| Largest sector | Banks 10% | Pharmaceuticals & Biotechnology 10% |